Experienced in Brain Tumor

Huseyin Mertsoylu

Adana Medical Park Hospital, 
Adana, TR 
Experienced in Brain Tumor
Adana Medical Park Hospital, 
Adana, TR 
OverviewLocationsClinical Research

Overview

Huseyin Mertsoylu practices in Adana, Turkey. Mertsoylu is rated as an Experienced expert by MediFind in the treatment of Brain Tumor. Their top areas of expertise are Nasopharyngeal Carcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Astrocytoma.

Their clinical research consists of co-authoring 56 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Brain Tumor.

Locations

Adana Medical Park Hospital, Adana, Turkey
Other Locations
Adana Medical Park Hospital, Istinye, Turkey
Clinics Of Radiation Oncology Medical Park Hospital, Antalya, Turkey
Baskent, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3

56 Total Publications

The global immune-nutrition-inflammation index (GINI) as a robust prognostic factor in glioblastoma patients treated with the standard stupp protocol.
The global immune-nutrition-inflammation index (GINI) as a robust prognostic factor in glioblastoma patients treated with the standard stupp protocol.
Journal: International journal of immunopathology and pharmacology
Published: September 21, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mertsoylu's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile